Uniphar PLC has acquired McCauley
February 2022 — Irish-listed healthcare group Uniphar PLC has acquired Dublin-headquartered McCauley Pharmacy Group, a prominent provider of pharmacy and retail services in Ireland and a market leader in the delivery of health, wellbeing and beauty products.
Uniphar is a global partner to pharmaceutical and medtech manufacturers working to improve patient access to medicines in Europe and around the world. It provides outsourced and specialized services to its clients and leverages strong relationships with over 200 of the world’s best-known pharmaco-medical manufacturers in multiple geographies. Uniphar operates across three core divisions: pharmaceuticals—a global business providing on-demand and medicine-sourcing solutions along with outsourced specialist services to pharmaceutical manufacturers; medtech—a leading European medical device distributor with a presence in 21 markets; and supply chain and retail—a market leader in Ireland with around 50% of the wholesale market and four nationwide pharmacy symbol groups. Uniphar is listed on the LSE and Euronext Dublin.
McCauley Pharmacy Group, a portfolio company of Carlyle Cardinal Ireland, was founded in 1953 as a single family-owned pharmacy store in Wexford, Ireland. The group now has 37 stores across Ireland, with the McCauley store footprint concentrated in the Leinster and Munster regions. The group employs around 450 people across its business, with about 42 staff in its head office and 54 pharmacists. McCauley provides a comprehensive RX and retail offering to the communities it serves. The group also provides a range of additional healthcare services to its customers, such as digital prescriptions, vaccine administration, online doctor services and pharmacist telephone consultations. In addition, McCauley has a significant online and e-commerce presence.
Our role in the transaction
Oaklins’ team in Ireland acted as the exclusive buy-side M&A advisor to Uniphar and assisted in all aspects, from initiating the transaction to structuring and negotiating premium deal terms. This deal complements a long list of acquisitions the team has advised on for Uniphar.
Talk to the deal team
Related deals
Rustins has been acquired by Remmers
Germany’s Remmers Gruppe SE has acquired UK coatings maker Rustins. The acquisition strengthens Remmers’ presence in the UK and expands its product portfolio and distribution channels. While Remmers has an established UK business focused on industrial flooring and wood coatings, Rustins brings complementary product ranges, established trade and distribution relationships and access to new customer groups in the DIY, painting and household retail sectors. Following completion, Rustins Group is wholly owned by Remmers, which has acquired all shares in Rustins Holdings Limited, including its operating company, Rustins Limited.
Learn moreMattina Holding has sold a 5% stake in Gens Aurea via accelerated bookbuild
Mattina Holding S.A. (DVC Partners) has sold a 5% stake in Italian company Gens Aurea S.p.A. through an accelerated bookbuild, raising approximately US$69.96 million.
Learn moreTNT has been acquired by PM Studio
TNT Group has been acquired by PM Studio Group, backed by Andera Partners, bringing together two complementary specialists in premium packaging for the beauty and luxury industries. TNT’s expertise in bespoke primary packaging complements PM Studio’s secondary packaging, gifting and creative design capabilities, creating a broader, integrated offering for major luxury brands. The transaction strengthens the group’s geographical footprint in Asia and the USA, diversifying its customer portfolio. The combined group generates over US$145 million in revenue and has approximately 150 employees worldwide. Following the transition of operational leadership to CEO Damon Kennish, the founders completed the sale to PM Studio while making a significant reinvestment alongside the management team, demonstrating their confidence in the combined group’s long-term potential. It aims to reach US$280 million in revenue by 2029 through organic growth, commercial synergies and further acquisitions.
Learn more